Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C). (Q46605816)
Jump to navigation
Jump to search
scientific article published in January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C). |
scientific article published in January 2008 |
Statements
1 reference
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C). (English)
1 reference
Bent Ejlertsen
1 reference
Jørn Andersen
1 reference
Claus Kamby
1 reference
Søren Cold
1 reference
Marianne Ewertz
1 reference
Erik H Jacobsen
1 reference
Preben Philip
1 reference
Knud A Møller
1 reference
Disa Jensen
1 reference
Susanne Møller
1 reference
1 January 2008
1 reference
1 reference
47
1 reference
4
1 reference
718-724
1 reference
1 reference
1 reference
Identifiers
1 reference